Bioera SpA
MIL:BIE

Watchlist Manager
Bioera SpA Logo
Bioera SpA
MIL:BIE
Watchlist
Price: 0.0388 EUR 17.58% Market Closed
Market Cap: 798.2k EUR
Have any thoughts about
Bioera SpA?
Write Note

Intrinsic Value

BIE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BIE stock under the Base Case scenario is 0.1384 EUR. Compared to the current market price of 0.0388 EUR, Bioera SpA is Undervalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIE Intrinsic Value
0.1384 EUR
Undervaluation 72%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioera SpA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIE?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bioera SpA

Provide an overview of the primary business activities
of Bioera SpA.

What unique competitive advantages
does Bioera SpA hold over its rivals?

What risks and challenges
does Bioera SpA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioera SpA.

Provide P/S
for Bioera SpA.

Provide P/E
for Bioera SpA.

Provide P/OCF
for Bioera SpA.

Provide P/FCFE
for Bioera SpA.

Provide P/B
for Bioera SpA.

Provide EV/S
for Bioera SpA.

Provide EV/GP
for Bioera SpA.

Provide EV/EBITDA
for Bioera SpA.

Provide EV/EBIT
for Bioera SpA.

Provide EV/OCF
for Bioera SpA.

Provide EV/FCFF
for Bioera SpA.

Provide EV/IC
for Bioera SpA.

Compare the intrinsic valuations
of Bioera SpA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioera SpA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioera SpA compared to its peers.

Compare the P/E ratios
of Bioera SpA against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioera SpA with its peers.

Analyze the financial leverage
of Bioera SpA compared to its main competitors.

Show all profitability ratios
for Bioera SpA.

Provide ROE
for Bioera SpA.

Provide ROA
for Bioera SpA.

Provide ROIC
for Bioera SpA.

Provide ROCE
for Bioera SpA.

Provide Gross Margin
for Bioera SpA.

Provide Operating Margin
for Bioera SpA.

Provide Net Margin
for Bioera SpA.

Provide FCF Margin
for Bioera SpA.

Show all solvency ratios
for Bioera SpA.

Provide D/E Ratio
for Bioera SpA.

Provide D/A Ratio
for Bioera SpA.

Provide Interest Coverage Ratio
for Bioera SpA.

Provide Altman Z-Score Ratio
for Bioera SpA.

Provide Quick Ratio
for Bioera SpA.

Provide Current Ratio
for Bioera SpA.

Provide Cash Ratio
for Bioera SpA.

What is the historical Revenue growth
over the last 5 years for Bioera SpA?

What is the historical Net Income growth
over the last 5 years for Bioera SpA?

What is the current Free Cash Flow
of Bioera SpA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioera SpA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioera SpA

Current Assets 748k
Cash & Short-Term Investments 181k
Receivables 554k
Other Current Assets 13k
Non-Current Assets 374k
PP&E 374k
Current Liabilities 8.1m
Accounts Payable 2.1m
Accrued Liabilities 93k
Short-Term Debt 3.2m
Other Current Liabilities 2.7m
Non-Current Liabilities 831k
Other Non-Current Liabilities 831k
Efficiency

Earnings Waterfall
Bioera SpA

Revenue
1.6m EUR
Cost of Revenue
-668k EUR
Gross Profit
924k EUR
Operating Expenses
-4.8m EUR
Operating Income
-3.8m EUR
Other Expenses
16.8m EUR
Net Income
13m EUR

Free Cash Flow Analysis
Bioera SpA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIE Profitability Score
Profitability Due Diligence

Bioera SpA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Positive Net Income
56/100
Profitability
Score

Bioera SpA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

BIE Solvency Score
Solvency Due Diligence

Bioera SpA's solvency score is 15/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
15/100
Solvency
Score

Bioera SpA's solvency score is 15/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIE Price Targets Summary
Bioera SpA

There are no price targets for BIE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bioera SpA Logo
Bioera SpA

Country

Italy

Industry

Consumer products

Market Cap

798.2k EUR

Dividend Yield

0%

Description

Bioera SpA is a holding company, which engages in the production and sale of organic products, natural cosmetics, and traditional food products. The company is headquartered in Milan, Milano and currently employs 3 full-time employees. The company went IPO on 2005-07-27. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The firm controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.

Contact

MILANO
Milan
Corso Di Porta Nuova 46
+390283963432
www.bioera.it

IPO

2005-07-27

Employees

3

Officers

CEO & Director
Dr. Giorgio Campeggio
Editor-in-Chief
Mr. Davide Guerra

See Also

Discover More
What is the Intrinsic Value of one BIE stock?

The intrinsic value of one BIE stock under the Base Case scenario is 0.1384 EUR.

Is BIE stock undervalued or overvalued?

Compared to the current market price of 0.0388 EUR, Bioera SpA is Undervalued by 72%.

Back to Top